October 21, 2016 | Story Review

Here we go again: TIME writes about preliminary mouse research

When there are so many bigger issues worth writing about, why is a small study involving 10 mice making headlines?

2 Star

How Omega 3 Fats May Improve Fertility

October 21, 2016 | Story Review

Are expensive, potent anti-inflammatory drugs a future option for depression? CNN’s story needed more scrutiny of evidence

Also: Neither the story nor the news release talked about the steep cost of this relatively new class of anti-inflammatories.

3 Star

Anti-inflammatory drugs might someday treat depression

October 20, 2016 | Story Review

NPR falls into the anecdotal trap with story on robotic arm for paralyzed man

This is a story about a case study involving one man and an experimental device. Such an anecdote is an imperfect way to report medical news and therefore needs lots of backstopping.

3 Star

Brain Implant Restores Sense Of Touch To Paralyzed Man

October 20, 2016 | Story Review

Potential conflicts of interest abound in HealthDay’s look at Lemtrada for early stages of MS

Readers need reminding that the manufacturer of a drug has an extremely strong interest in getting their drug used as early as possible in a disease process and that measures of “benefit” need to correspond to this early use.

3 Star

Powerful MS Drug Used Early May Reverse Some Disability

October 14, 2016 | Story Review

PARP inhibitors: STAT’s look at new ovarian cancer drugs should have established why we need more on the market

Do we really need more PARP inhibitors beyond the one that’s already approved? If so, why? This story didn’t clarify these things for readers.

3 Star

The race to create a new class of ovarian cancer drugs heats up

October 12, 2016 | Story Review

Reuters’ ‘New day in lung cancer’ presents overly rosy picture of Keytruda

The story shares the seemingly good news for lung cancer patients without noting that the drug under investigation only amounted to a few extra months of cancer not spreading, compared to standard treatment.

3 Star

New day' in lung cancer as Merck drug shines, works with chemo

October 10, 2016 | Story Review

NBC story on severe incontinence study lacked independent sources

It also attempted to discuss cost, but provided no prices, and didn’t go far enough in detailing the potential harms of either treatment.

3 Star

Botox Works As Well As Nerve Stimulator for Incontinence - Study

October 7, 2016 | Story Review

Experimental immunotherapy for kids with leukemia gets balanced coverage by Washington Post

Readers get the full sense of how experimental this treatment is, and how it’s a last-resort option.

5 Star

This 8-year-old is free of cancer — for now — after a ‘breakthrough’ treatment


Tips for Understanding Studies

View More